Search Results 211-220 of 24237 for Ovary
... ovarian cancer scheduled to undergo primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery. Participation eligibility.
The purpose of this study is to extract ovarian and uterine cancer patients' phenotypes at diagnosis and cancer treatments (side-effects, symptoms and clinical ...
Ovarian cancer, the deadliest of the reproductive organ cancers, often goes ... At this late stage, ovarian cancer is more difficult to treat and is frequently ...
Ovarian hyperstimulation syndrome (OHSS). Fertility medicines can cause this condition in which the ovaries become swollen and painful. The risk of OHSS goes up ...
Ovarian cancer, the deadliest of the reproductive organ cancers, often goes undetected until it has spread within the pelvis and abdomen. At this late stage, ...
According to the Centers for Disease Control and Prevention, more than 20,000 women in the U.S. are diagnosed with ovarian cancer each year.
This phase II trial studies how well auranofin and sirolimus work in treating participants with ovarian cancer. Immunosuppressive therapy, such as auranofin ...
Ovarian Cancer/Family Dysfunction/Tips To Lower Blood Pressure: Mayo Clinic Radio ... According to the American Cancer Society, about 21,000 women will be ...
A Study of Vulvovaginal Symptoms in Premenopausal Stage 0-III Breast Cancer Patients Treated on Aromatase Inhibitors and Ovarian Suppression · Overview.
Recent advances in reproductive endocrinology allow cryopreservation of prepubertal boys' testicular tissue and girls' ovarian tissue before they begin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.